The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Securities

17 Jul 2020 07:07

RNS Number : 3276T
Oilex Ltd
17 July 2020
 

ASX - RNS Announcement

 

17 July 2020

 

 

ASX: OEX

AIM: OEX

 

 

Re: Issue of Securities

 

Oilex Ltd (Oilex or the Company) is pleased to announce it has issued the second and final tranche of 55,555,556 ordinary shares pursuant to the placement first announced on 16 March 2020, and amended as announced on 27 April 2020 (Second Tranche Shares). The share issue was pursuant to an equity capital raising to secure further funding of £0.25 million (A$0.5 million) through the subscription of 277,777,778 new shares (Subscription Shares) at £0.009 per share (0.1792 AUD cents) per share (Subscription).

 

The Company also announces the issue of 103,033,333 shares to advisors and consultants in lieu of cash fees payable. The issue of 84,810,000 shares to advisors and consultants was approved by shareholders on 30 June 2020, with the balance of 18,223,333 shares at £0.009 per share issued to the Company's legal advisors under the Company's listing rule 7.1 capacity.

 

An Appendix 2A pursuant to the issue of the 55,555,556 shares pursuant to the placement and 103,033,333 shares to advisors and consultants is attached to this announcement. http://www.rns-pdf.londonstockexchange.com/rns/3276T_1-2020-7-17.pdf An Appendix 3B for the proposed issue of 18,223,333 shares to the Company's legal advisors has been announced separately. http://www.rns-pdf.londonstockexchange.com/rns/3276T_2-2020-7-17.pdf

 

Issue of Unlisted Options

 

Further to the approval by shareholders at the meeting held on 30 June 2020 and Appendix 3B as announced on 15 May 2020, the Company advises that it has issued the following unlisted options:

 

Series B Options 115,727,273 exercisable at £0.0011 on or before 31 July 2020

Series D Options 204,545,455 exercisable at £0.0011 on or before 30 June 2021

 

AIM Admission and Total Voting Rights

 

Application has been made to the London Stock Exchange plc for the admission of, in aggregate, 158,588,889 ordinary shares (comprising the Second Tranche Shares and the Advisor Shares) to trading on AIM (Admission). Admission of the Second Tranche Shares and the Advisor Shares is expected to become effective and dealings to commence at 8.00 a.m. on 24 July 2020. Following Admission of the Second Tranche Shares and the Advisor Shares, the Company will have 3,807,129,999 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 3,807,129,999.

 

 

 

Section 708A(5)(e) Statement

 

Pursuant to the issue of the Second Tranche Shares and the Advisor Shares, Oilex gives notice under section 708A(5)(e) of the Corporations Act (Cth) (Act) that:

 

1) Oilex issued the Shares without disclosure to investors under Part 6D.2 of the Act;

 

2) As at the date of this notice, Oilex has complied with:

a) the provisions of Chapter 2M of the Act as they apply to Oilex; and

b) section 674 of the Act; and

 

3) As at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708(8) of the Act.

 

For and on behalf of Oilex Ltd

 

 

Mark Bolton

Executive Director and Company Secretary

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEGPUWUMUPUUQM
Date   Source Headline
7th Aug 20209:32 amRNSTermination of JPDA Arbitration Proceedings
31st Jul 202011:07 amRNSJune 2020 Quarterly Report
31st Jul 202010:45 amRNSLoan Restructure and Equity Issue
30th Jul 20209:00 amRNSManaging Director Contract Extension
27th Jul 20207:00 amRNSWest Kampar Update
17th Jul 20207:07 amRNSIssue of Securities
30th Jun 202010:40 amRNSSuccessful Bid for Cooper Basin Permit
30th Jun 20208:17 amRNSResults of General Meeting
30th Jun 20208:11 amRNSExecutive Director Contract Extension
30th Jun 20208:05 amRNSChange of Registered Office
29th Jun 20207:00 amRNSIndia Update
15th Jun 202010:28 amRNSChange to Notice of Meeting
15th Jun 20207:56 amRNSArmour Share Purchase Agreement
5th Jun 202011:52 amRNSExtension to Armour Agreement
3rd Jun 20201:14 pmRNSNotice of Change of Interest of Substantial Holder
1st Jun 20207:15 amRNSExtension to Armour Agreement
29th May 20207:00 amRNSNotice of General Meeting
27th May 20209:28 amRNSSale of Cooper Eromanga Basin Assets
26th May 20207:00 amRNSNotice of Change of Interest of Substantial Holder
15th May 20207:00 amRNSIssue of Securities
6th May 20207:00 amRNSAppendix 3Z B Lingo
6th May 20207:00 amRNSReplacement Appendix 5B
5th May 20208:36 amRNSBoard Changes
30th Apr 20209:16 amRNSMarch 2020 Quarterly Report
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
28th Apr 202011:02 amRNSCooper Basin Update
27th Apr 20207:14 amRNSCorrection: Variation to Financing Terms
23rd Apr 20201:45 pmRNSVariation to Financing Terms
3rd Apr 20207:00 amRNSChairman Consulting Contract Extension
3rd Apr 20207:00 amRNSExtension for Acquisition of Cooper Licences
26th Mar 20207:32 amRNSAppendix 3X Mark Bolton
26th Mar 20207:00 amRNSBoard and Executive Changes
24th Mar 20207:30 amRNSDoriemus Transaction - Update
16th Mar 20207:15 amRNSInterim Report 31 December 2019
16th Mar 20207:00 amRNSBusiness and Financial Restructure
12th Mar 20207:00 amRNSDoriemus Shareholders Approve Transaction
6th Mar 20207:15 amRNSOpportunity to Participate in Doriemus Offer
3rd Mar 202012:24 pmRNSUpdate on Cambay Sale Process
28th Feb 20209:29 amRNSExtension for Acquisition of Cooper Basin Licences
21st Feb 20207:30 amRNSStrong Funding Support for Cooper-Eromanga
11th Feb 20207:00 amRNSChairman Consulting Contract Extension
4th Feb 20207:00 amRNSAppendix 3B: Issue of Securities
3rd Feb 20202:23 pmRNSNew Series C Loan Facility
31st Jan 20208:17 amRNSDecember 2019 Quarterly Report
30th Jan 20207:00 amRNSDOR - Prop Acqn of Major Cooper-Eromanga Portfolio
29th Jan 202010:39 amRNSSale of Cooper Eromanga Basin Assets
28th Jan 20207:00 amRNSSale of Participating Interest in Bhandut
17th Jan 20202:05 pmRNSUpdate on Cambay Sale Process
7th Jan 20207:34 amRNSNotice of Change of Interest of Substantial Holder

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.